Lysanne A. Lievense

Breda, NB, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Clinical Outcomes of Patients With Metastatic NSCLC After Discontinuation of Immunotherapy Because of Immune-Related Adverse Effects.

Clinical Outcomes of Patients With Metastatic NSCLC After Discontinuation of Immunotherapy Because of Immune-Related Adverse Effects.

Journal: JTO clinical and research reports

Published: July 12, 2022

Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response.

Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response.

Journal: EBioMedicine

Published: July 23, 2020

Checkpoint Blockade in Lung Cancer and Mesothelioma.

Checkpoint Blockade in Lung Cancer and Mesothelioma.

Journal: American journal of respiratory and critical care medicine

Published: March 03, 2017

Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy.

Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy.

Journal: Cancer immunology research

Published: November 04, 2016

Efficacy of Tumor Vaccines and Cellular Immunotherapies in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Efficacy of Tumor Vaccines and Cellular Immunotherapies in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 20, 2016

Pleural Effusion of Patients with Malignant Mesothelioma Induces Macrophage-Mediated T Cell Suppression.

Pleural Effusion of Patients with Malignant Mesothelioma Induces Macrophage-Mediated T Cell Suppression.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: March 28, 2016

Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patients.

Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patients.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 01, 2016

Immune Therapy.

Immune Therapy.

Journal: Advances in experimental medicine and biology

Published: December 16, 2015

Intratumoral macrophage phenotype and CD8+ T lymphocytes as potential tools to predict local tumor outgrowth at the intervention site in malignant pleural mesothelioma.

Intratumoral macrophage phenotype and CD8+ T lymphocytes as potential tools to predict local tumor outgrowth at the intervention site in malignant pleural mesothelioma.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 02, 2014

Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma.

Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma.

Journal: PloS one

Published: January 31, 2014

Biomarkers for immune checkpoint inhibitors.

Biomarkers for immune checkpoint inhibitors.

Journal: The Lancet. Oncology

Published: January 04, 2014

Immunotherapy prospects in the treatment of lung cancer and mesothelioma.

Immunotherapy prospects in the treatment of lung cancer and mesothelioma.

Journal: Translational lung cancer research

Published: September 11, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026